Fortress Biotech, Inc. (FBIO)
Nasdaq: FBIO · Pharmaceutical Preparations · Bay Harbor Islands, FL · filing with the SEC since 2008
Who runs Fortress Biotech, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Rosenwald Lindsay A Md
PRESIDENT, CEO & CHAIRMAN. First filing Sep 2011, latest Mar 20, 2026, 19 filings in all.
Officers reporting now
3
of 8 people with a filing in the last fifteen months
Directors reporting now
5
12 people on the record since 2011
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jin David | Chief Financial Officer | Aug 2022 | Oct 1, 2026 | none |
| Rosenwald Lindsay A Md | PRESIDENT, CEO & CHAIRMAN | Sep 2011 | Mar 20, 2026 | none |
| Weiss Michael S | Executive Vice Chairman | Dec 2013 | Mar 20, 2026 | none |
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Harvey Jimmie | director | Sep 2011 | Jan 5, 2026 | none |
| Hoenlein Malcolm | director | Feb 2014 | Jan 5, 2026 | none |
| Klein Dov | director | Jul 2015 | Jan 5, 2026 | none |
| Lobell J Jay | director | Sep 2011 | Jan 5, 2026 | none |
| Lorenz Kevin | director | Dec 2019 | Jan 5, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.